The EU IVDR is the new legislation applicable to IVD medical devices being placed on the EU market. Entering into force on the 25 May 2017 marking the start of a five-year transition period for manufacturers and economic operators, the IVDR replaces the EU In Vitro Diagnostics Directive (IVDD) 98/79/EC. Manufacturers wishing to apply to a notified body for a conformity assessment of their IVD medical device have until the Date of Application of the IVDR in May 2022 to update their Technical Documentation to meet the requirements and comply with the new, more stringent Regulation.
The EU IVDR brings with it significant changes to the regulatory requirements for IVD medical device manufacturers and introduces a new rule-based classification system with stricter notified body oversight, as well as significant changes to the depth and requirements of the associated Technical Documentation. It also brings changes to the relationship between manufacturers and economic operators.
For IVD medical device manufacturers that are currently self-declaring conformity under the IVDD, May 2022 is the final deadline for a manufacturer to have received successful CE certification by a notified body. This new rule-based classification system supersedes the current list-based approach in the IVDD.